Successful etanercept therapy for refractory sacroiliitis in a patient with ankylosing spondylitis and mixed connective tissue disease

Yonsei Medical Journal

Volumn 49, Issue 1, 2008, Pages 159-162

  Lee, Jee Young ^a   Chang, Hyun Kyu ^b   Kim, Seong Kyu ^c  

^a Dankook University   (South Korea)

^b Chang Hyn Kyu Rheumatism Clinic   (South Korea)

^c The Catholic University of Korea   (South Korea)

Author keywords

Ankylosing spondylitis; Ctanercept; Mixed connective tissue disease

Indexed keywords

ANTINUCLEAR ANTIBODY; CALCIUM CHANNEL BLOCKING AGENT; CORTICOSTEROID; ETANERCEPT; HLA B27 ANTIGEN; HYDROXYCHLOROQUINE; NONSTEROID ANTIINFLAMMATORY AGENT; RIBONUCLEOPROTEIN ANTIBODY; STEROID; TRIAMCINOLONE ACETATE;

ADULT; ANKYLOSING SPONDYLITIS; ARTHRALGIA; ARTICLE; BUTTOCK; CASE REPORT; COMBINATION CHEMOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; DRUG DOSE REGIMEN; DRUG RESPONSE; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FINGER; HAND EDEMA; HUMAN; INFRARED PHOTOGRAPHY; LOW BACK PAIN; LOW DRUG DOSE; LUPUS LIKE SYNDROME; MIXED CONNECTIVE TISSUE DISEASE; MORNING STIFFNESS; NUCLEAR MAGNETIC RESONANCE IMAGING; PELVIS RADIOGRAPHY; PHOTOSENSITIVITY; PHYSICAL EXAMINATION; POLYARTHRITIS; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; REST; SACROILIITIS; SHOULDER PAIN; TREATMENT DURATION; TREATMENT OUTCOME;

FEMALE; HUMANS; IMMUNOGLOBULIN G; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; RECEPTORS, TUMOR NECROSIS FACTOR; SACROILIAC JOINT; SPONDYLITIS, ANKYLOSING; TREATMENT OUTCOME;

EID: 41949119998     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2008.49.1.159     Document Type: Article

References (16)

1. Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR. Mixed connective tissue disease-an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 1972;52:148-59.
2. Alarcón-Segovia D, Cardiel MH. Comparison between 3 diagnostic criteria for mixed connective tissue disease. Study of 593 patients. J Rheumatol 1989;16: 328-34.
3. Lee JK, Jung SS, Kim TH, Jun JB, Yoo DH, Kim SY. Coexistence of ankylosing spondylitis and mixed connective tissue disease in a single patient. Clin Exp Rheumatol 1999;17:263.
4. Brandt J, Maier T, Rudwaleit M, Kühl U, Hiepe F, Sieper J, et al. Co-occurrence of spondyloarthropathy and connective tissue disease: development of Sjögren's syndrome and mixed connective tissue disease (MCTD) in a patient with ankylosing spondylitis. Clin Exp Rheumatol 2002;20:80-4.
5. Richez C, Blanco P, Dumoulin C, Schaeverbeke T. Lupus erythematosus manifestations exacerbated by etanercept therapy in a patient with mixed connective tissue disease. Clin Exp Rheumatol 2005;23:273.
6. Christopher-Stine L, Wigley F. Tumor necrosis factor-alpha antagonists induce lupus-like syndrome in patients with scleroderma overlap/mixed connective tissue disease. J Rheumatol 2003;30:2725-7.
7. Braun J, Brandt J, Listing J, Zink A, Alten R, Golder W, et al. Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial. Lancet 2002;359:1187-93.
8. Brandt J, Khariouzov A, Listing J, Haibel H, Sörensen H, Grassnickel L, et al. Six-month results of a double-blind, placebo-controlled trial of etanercept treatment in patients with active ankylosing spondylitis. Arthritis Rheum 2003;48:1667-15.
9. van der Linden S, Valkenburg HA, Cats A. Evaluation of diagrostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
10. Alarcon-Segovia D, Villareal M. Classification and diagnostic criteria for mixed connective tissue disease. In: Kasukawa R, Sharp GC, editors. Mixed Connective Tissue Disease and Anti-nuclear Antibodies. Amsterdam: Elsevier; 1987. p.33-40.
11. Brandt J, Rudwaleit M, Eggens U, Mertz A, Distler A, Sieper J, et al. Increased frequency of Sjögren's syndrome in patients with spondyloarthropathy. J Rheumatol 1998;25:718-24.
12. Scotto di Fazano C, Grilo RM, Vergne P, Coyral D Inaoui R, Bonnet C, et al. Is the relationship between spondyloarthropathy and Sjögren's syndrome in women coincidental? A study of 13 cases. Joint Bone Spine 2002;69:383-7.
13. Kim P, Grossman JM. Treatment of mixed connective tissue disease. Rheum Dis Clin North Am 2005;31:549-65, viii.
14. Scott DL, Kingsley GH. Tumor necrosis factor inhibitors for rheumatoid arthritis. N Engl J Med 2006;355: 704-12.
15. Shanahan JC, St Clair W. Tumor necrosis factor-alpha blockade: a novel therapy for rheumatic disease. Clin Immunol 2002;103:231-42.
16. Rudwaleit M, Baraliakos X, Listing J, Brandt J, Sieper J, Braun J. Magnetic resonance imaging of the spine and the sacroiliac joints in ankylosing spondylitis and undifferentiated spondyloarthritis during treatment with etanercept. Ann Rheum Dis 2005;64:1305-10.